Celltrion has partnered with Japan’s largest bio cluster, the Kobe Biomedical Innovation Cluster (KBIC), to support the global expansion of promising biotech startups. The collaboration was announced at an offline briefing held on the 8th at the Tokyo LINK‑J (Life Science Innovation Network Japan) headquarters.
The initiative, named the “2026 KBIC‑Celltrion Global Scale‑up Program,” marks the first time a Korean company co‑plans and operates a program with a Japanese bio cluster, representing a historic Korea‑Japan public‑private partnership aimed at accelerating biotech innovation and market entry.
Noticias diarias20 sept 2026•1 min de lectura
Celltrion & Kobe Cluster Launch 2026 Global Scale‑up Program
Celltrion announced a partnership with Japan’s Kobe Biomedical Innovation Cluster, launching the 2026 KBIC‑Celltrion Global Scale‑up Program to help promising biotech startups expand globally.
Recopilado por el equipo de PharmaCountry · Fuente: KPA News
Calificaciones
(0)
(0)
(0)
(0)
(0)
Más artículos
Ver todos los artículosInvestigación e Informes
Global Finished Dosage Manufacturing Landscape 2026
5 oct 2026
Actualizaciones regulatoriasKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept 2026
AnálisisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept 2026
Deja tu valoración